Εμφάνιση απλής εγγραφής

dc.creatorRouka E., Kotsiou O.S., Perlepe G., Pagonis A., Pantazopoulos I., Gourgoulianis K.I.en
dc.date.accessioned2023-01-31T09:51:54Z
dc.date.available2023-01-31T09:51:54Z
dc.date.issued2021
dc.identifier10.1155/2021/6590528
dc.identifier.issn11982241
dc.identifier.urihttp://hdl.handle.net/11615/78567
dc.description.abstractBackground. The direct effect of SARS-CoV-2 on the lungs results in increased hospitalization rates of patients with pneumonia. Severe COVID-19 patients often develop ARDS which is associated with poor prognosis. Assessing risk factors for COVID-19 severity is indispensable for implementing and evaluating therapeutic interventions. We investigated the temporal associations between the SARS-CoV-2 antigen (Ag), total Immunoglobulin (Ig) levels, and several laboratory parameters in hospitalized patients with varying degrees of COVID-19 severity. Methods. The SARS-CoV-2 nucleocapsid protein (NP) and total Ig Spike (S) protein-specific antibodies were determined for each patient with lateral flow assays through repeated sampling every two days. Hematological and biochemical parameters were evaluated at the same time points. Results. 40 Greek COVID-19 patients (31 males, 9 females) with a median age of 59.50 ± 16.21 years were enrolled in the study. The median time from symptom onset to hospitalization was 8.0 ± 4.19 days. A significant negative correlation was observed between the SARS-CoV-2 Ag and total Ig levels. The temporal correlation patterns of the SARS-CoV-2 NP Ag and anti-S total Ig levels with laboratory markers varied among patients with differing degrees of COVID-19 severity. Severe-critical cases had lower SARS-CoV-2 Ag and increased total Ig levels as compared to mild-moderate cases. Conclusions. Distinct temporal profiles of the SARS-CoV-2 NP Ag and anti-S total Ig levels may distinguish different groups of COVID-19 severity. © 2021 Erasmia Rouka et al.en
dc.language.isoenen
dc.sourceCanadian Respiratory Journalen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85116694398&doi=10.1155%2f2021%2f6590528&partnerID=40&md5=67b5550d8addacc7c8bd0ddaaa77586d
dc.subjectalanine aminotransferaseen
dc.subjectC reactive proteinen
dc.subjectcoronavirus nucleocapsid proteinen
dc.subjectcoronavirus spike glycoproteinen
dc.subjectcreatinineen
dc.subjectD dimeren
dc.subjectferritinen
dc.subjectimmunoglobulin Aen
dc.subjectimmunoglobulin Gen
dc.subjectimmunoglobulin Men
dc.subjectlactate dehydrogenaseen
dc.subjectlactic aciden
dc.subjectSARS-CoV-2 antibodyen
dc.subjectureaen
dc.subjectimmunoglobulinen
dc.subjectvirus antigenen
dc.subjectacute kidney failureen
dc.subjectadulten
dc.subjectadult respiratory distress syndromeen
dc.subjectageden
dc.subjectArticleen
dc.subjectcardiovascular diseaseen
dc.subjectclinical articleen
dc.subjectcohort analysisen
dc.subjectcoronavirus disease 2019en
dc.subjectdisease severityen
dc.subjectfemaleen
dc.subjecthospital patienten
dc.subjecthospitalizationen
dc.subjecthumanen
dc.subjectlateral flow immunochromatographyen
dc.subjectlength of stayen
dc.subjectleukocyte counten
dc.subjectlymphocyte counten
dc.subjectmaleen
dc.subjectmultiple organ failureen
dc.subjectneutrophil counten
dc.subjectplatelet counten
dc.subjectpneumoniaen
dc.subjectprospective studyen
dc.subjectreal time reverse transcription polymerase chain reactionen
dc.subjectsensitivity and specificityen
dc.subjectSevere acute respiratory syndrome coronavirus 2en
dc.subjectsmokingen
dc.subjectenzyme linked immunosorbent assayen
dc.subjectepidemiologyen
dc.subjectfollow upen
dc.subjectGreeceen
dc.subjectimmunologyen
dc.subjectmiddle ageden
dc.subjectpandemicen
dc.subjectvery elderlyen
dc.subjectvirologyen
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectAntigens, Viralen
dc.subjectCoronavirus Nucleocapsid Proteinsen
dc.subjectCOVID-19en
dc.subjectEnzyme-Linked Immunosorbent Assayen
dc.subjectFemaleen
dc.subjectFollow-Up Studiesen
dc.subjectGreeceen
dc.subjectHumansen
dc.subjectImmunoglobulinsen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectPandemicsen
dc.subjectProspective Studiesen
dc.subjectSARS-CoV-2en
dc.subjectHindawi Limiteden
dc.titleTemporal Associations of the SARS-CoV-2 NP Antigen and Anti-Spike Total Ig Levels with Laboratory Parameters in a Greek Cohort of Hospitalized COVID-19 Patientsen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής